Correction: Drug development for rare diseases: a case for patient-centricity, equity, and access to clinical trials
Saved in:
| Main Authors: | Allison E. Bowen, Satish Nargundkar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Journal of Rare Diseases |
| Online Access: | https://doi.org/10.1007/s44162-025-00101-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
On Student Access and Equity in a Reforming University:
by: Kwesiga, Joy Constance
Published: (2018) -
Correction: Moving towards deep equity, diversity, inclusivity and accessibility in simulation: a call to explore the promises and perils
by: Peter Dieckmann, et al.
Published: (2025-08-01) -
Private Data Incrementalization: Data-Centric Model Development for Clinical Liver Segmentation
by: Stephanie Batista, et al.
Published: (2025-05-01) -
Pressure centric to patient centric glaucoma care: Connecting the dots
by: Lathika V. Kamaladevi
Published: (2025-01-01) -
Mapping the rare disease paediatric clinical trial availabilities in Europe
by: Eva Degraeuwe, et al.
Published: (2025-05-01)